Mauritania’s Council of Ministers adopted a draft decree on 21 October regulating the domestic manufacture of medicines and other health products, according to the communiqué reported by Sahara Media. (fr.saharamedias.net)
The government said the measure would close a regulatory gap and provide a framework for developing a national pharmaceutical industry. Its stated objectives are to improve medicine availability, reduce import dependence and strengthen health sovereignty. These are policy aims, not evidence that domestic production has already increased. (fr.saharamedias.net)
The announcement concerns regulation rather than the opening of a factory or delivery of a new production line. The available report did not identify a quantified manufacturing target or timetable for measurable reductions in imports. (fr.saharamedias.net)